The Crysvita market is witnessing steady growth over the forecast period, supported by growth in rare disease screening, expansion of adult xlh treatment.
Read More
The Crosseal market is witnessing steady growth over the forecast period, supported by growth in orthopedic and cardiac surgeries, expansion of outpatient surgical centers.
Read More
The Crofab market is witnessing steady growth over the forecast period, supported by expansion of emergency care access, rising awareness of snakebite management.
Read More
The Creon market is witnessing steady growth over the forecast period, supported by growth in chronic digestive disorders, rising aging population.
Read More
The Cotazym market is witnessing steady growth over the forecast period, supported by growth in chronic pancreatitis cases, expanding geriatric population.
Read More
The Cosentyx Drug market is witnessing steady growth over the forecast period, supported by growth in autoimmune disease diagnosis, expansion of treatment indications.
Read More
Proteasome inhibitors market to reach $3.49 billion by 2030 at 10.2% CAGR, driven by increasing prevalence of pancreatic cancer.
Read More
Prostate Cancer Therapeutics Market Research 2026: Market Size, Trends, Segments And Growth Forecast
Prostate cancer therapeutics market to reach $19.25 billion by 2030 at 8.4% CAGR, driven by increasing incidence of prostate cancer.
Read More
Prostate cancer drugs market to reach $26.15 billion by 2030 at 6.2% CAGR, driven by increasing men geriatric population.
Read More
Propranolol drug market to reach $1.41 billion by 2030 at 5.2% CAGR, driven by growing prevalence of cardiovascular diseases.
Read More